Literature DB >> 712074

Plasmacytomas of the NZB mouse.

H C Morse, R Riblet, R Asofsky, M Weigert.   

Abstract

Plasmacytomas were readily induced in NZB mice by three i.p. inoculations with pristane (2, 6, 10, 14-tetramethylpentadecane). In comparison with comparable induction regimens in BALB/c mice a) the latent period for plasmacytoma development was significantly longer in NZB's; b) the frequency of IgA paraproteins produced by NZB tumors was much reduced and that of IgG (IgG1, IgG2a, IgG2b, IgG3Y was significantly increased; and c) the frequency of carbohydrate-binding paraproteins was 10-fold lower. There was a high frequency of primary ascites containing more than one paraprotein, but none of 25 such tumors produced more than one immunoglobulin class on serial transplantation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility.

Authors:  Ke Zhang; Daniel Kagan; Wendy DuBois; Richard Robinson; Valery Bliskovsky; William C Vass; Shuling Zhang; Beverly A Mock
Journal:  Blood       Date:  2009-08-04       Impact factor: 22.113

2.  Changes in the DNA of lymphocytes from pristane treated rats.

Authors:  L R Garrett; K L Bost; T M Buttke; M A Cuchens
Journal:  Agents Actions       Date:  1987-02

3.  The organization of the mouse Igh-V locus. Dispersion, interspersion, and the evolution of VH gene family clusters.

Authors:  P H Brodeur; G E Osman; J J Mackle; T M Lalor
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

4.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

5.  Somatic mutation creates diversity in the major group of mouse immunoglobulin kappa light chains.

Authors:  G Heinrich; A Traunecker; S Tonegawa
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.